Brainstem auditory evoked response in newborns with hyperbilirubinemia.
Indian Pediatr
;
1998 Jun; 35(6): 513-8
Article
Dans Anglais
| IMSEAR
| ID: sea-11031
ABSTRACT
OBJECTIVE:
To determine the initial Brainstem Auditory Evoked Response (BAER) abnormalities in neonates with hyperbilirubinemia and the possible reversibility of abnormal BAER after therapy.DESIGN:
Prospective cohort study.SETTING:
Tertiary care hospital.SUBJECTS:
30 term neonates with hyperbilirubinemia (S. bilirubin < 15 mg/dl) as cases and 25 normal term neonates as controls.METHODS:
Duration of study was from August 1995 to August 1996. BAER were recorded before therapy at peak hyperbilirubinemia, after therapy, and the age of 2-4 months using electric response audiometer (Nihon Neuropack Four Machine). Denver Development Screening Test (Denver II) was performed at 1 year of age.RESULTS:
Seventeen out of thirty (56.7%) neonates with hyperbilirubinemia showed abnormalities on initial BAER. Commonest abnormality seen was raised threshold of wave V in 12 neonates (40%). Other abnormalities observed were absence of all waves at 90 dB (23.3%), prolongation of latencies of various waves (26.7%) and prolongation of various intervals (26.7%). Abnormalities in BAER correlated significantly with bilirubin level. After therapy abnormalities reverted back to normal in 10 cases but persisted in 7 out of 17 (41.17%) cases with initial abnormal BAER. Development screening at 1 yr was abnormal in 3 infants all of whom had persistent abnormalities in BAER.CONCLUSION:
Serial BAER is a useful, non invasive tool to detect neurodevelopment delay secondary to neonatal hyperbilirubinemia.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Seuil auditif
/
Bilirubine
/
Femelle
/
Humains
/
Mâle
/
Nouveau-né
/
Études cas-témoins
/
Dépistage de masse
/
Études prospectives
/
Potentiels évoqués auditifs du tronc cérébral
Type d'étude:
Étude observationnelle
/
Étude de dépistage
langue:
Anglais
Texte intégral:
Indian Pediatr
Année:
1998
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS